INNOSPEC INTERNATIONAL LIMITED – Trademark Portfolio
Entity Type: 03
INNOSPEC INTERNATIONAL LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include STADIS and ORTHOLEUM. The owner is based in CHESHIRE.
OIL SITES ROAD; ELLESMERE PORT
INNOSPEC MANUFACTURING PARK
CHESHIRE CH65 4EY , GB
Showing of trademarks Trademarks
Trademark Classifications
INNOSPEC INTERNATIONAL LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does INNOSPEC INTERNATIONAL LIMITED have?
INNOSPEC INTERNATIONAL LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does INNOSPEC INTERNATIONAL LIMITED file in?
INNOSPEC INTERNATIONAL LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 4 (Lubricants & Fuels). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are INNOSPEC INTERNATIONAL LIMITED's most well-known trademarks?
INNOSPEC INTERNATIONAL LIMITED's registered trademark portfolio includes well-known marks such as STADIS and ORTHOLEUM. These are among 2 currently registered trademarks in the portfolio.
What is INNOSPEC INTERNATIONAL LIMITED's trademark registration success rate?
INNOSPEC INTERNATIONAL LIMITED has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.